H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS This group comprises all hormonal preparations for systemic use, except: - Insulins, see A10. - Anabolic steroids, see A14. - Catecholamines, see C01C and R03C. - Sex hormones, see G03. - Sex hormones used in treatment of neoplastic diseases, see L02. The DDDs are generally based on the treatment or diagnosis of endocrine disorders. H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES H02 CORTICOSTEROIDS FOR SYSTEMIC USE As a main rule, systemic corticosteroids should be classified in this group. There is, however, one exception: M01BA - Antiinflam-matory/antirheumatic agents in combination with corticosteroids. Corticosteroids for local oral treatment, see A01AC. Enemas and rectal foams for local treatment of e.g. ulcerative colitis, see A07E. Corticosteroids for topical use, see D07. Combined corticosteroid preparations for local treatment of acne, see D10AA. Corticosteroids in combination with antiinfectives/antiseptics for local treatment of gynecological infections, see G01B. Corticosteroids for nasal use, see R01AD. Corticosteroids for inhalation, see R03BA. Corticosteroids, eye/ear preparations, see S. H03 THYROID THERAPY H04 PANCREATIC HORMONES H05 CALCIUM HOMEOSTASIS Drugs acting on calcium homeostasis are classified in this group. Vitamin-D preparations, see A11CC.

Classification of drugs affecting hormones expect for sexual hormones and insulin.

Sirarat Sarntivijai